http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108864101-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate | 2017-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108864101-B |
| titleOfInvention | Deuterated SGX523 and application thereof |
| abstract | the invention relates to a deuterated SGX523 and application thereof, in particular to deuterated 6- ((6- (1-methyl-1H-pyrazol-4-yl) - [1,2,4] shown in a formula (I)]-triazolo [4,3-b]Pyridazin-3-yl) thio) quinoline compounds or pharmaceutically acceptable salts thereof, a preparation method and a pharmaceutical composition thereof, and application of the compounds in preparing medicaments for preventing or treating diseases mediated by protein tyrosine kinase signals. |
| priorityDate | 2017-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 232.